Weihong Wei
4 Papers
39 Citations
Weihong Wei is an academic researcher. The author has contributed to research in topics: Nasopharyngeal carcinoma & Cancer. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma
Tao Xu,Bojin Su,Chunhua Wang,Sumei Wang,Hecheng Huang,Yunbao Pan,Donghui Wang,Weihong Wei,Francois X. Claret,Huiling Yang +9 more
TL;DR: Differences between short- and long-term ITR may predict outcome in nasopharyngeal carcinoma, and the overexpression of Jab1/Csn5 and Akt may contribute to the carcinogenesis of rNPC, andAkt seems to promote the progression of short- term ITR.
Clinical implications of hepatitis B viral infection in Epstein–Barr virus-associated nasopharyngeal carcinoma
Tao Xu,Zeli Huang,Yanming Deng,Sumei Wang,Sumei Wang,Bojin Su,Weihong Wei,Donghui Wang,Jun Jiang,Anfei Li,Guoyi Zhang,Huiling Yang,Francois X. Claret,Francois X. Claret,Weihan Hu +14 more
TL;DR: Both HBV and EBV infection is an independent negative prognostic factor for long-term survival, distant metastasis, especially liver metastasis was more common in NPC patients with HBsAg(+), and it seemed no link between EBV DNA load andHBsAg status in NPC.
15
Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinoma
Tao Xu,Zheli Huang,Bojin Su,Sumei Wang,Donghui Wang,Chunhua Wang,Weihong Wei,Jun Jiang,Guoyi Zhang,Huiling Yang,Weihan Hu +10 more
TL;DR: This study demonstrates the clinical value of circulating CD19+ B cell measurements in NPC patients and investigates the correlation between pre- and post-treatment plasma EBV DNA and circulating immune subsets as well as the prognostic implications in nasopharyngeal carcinoma patients.
14
Novel biomarkers of nasopharyngeal carcinoma metastasis risk identified by reverse phase protein array based tumor profiling with consideration of plasma Epstein–Barr virus DNA load
Tao Xu,Tao Xu,Bojin Su,Bojin Su,Peiyu Huang,Peiyu Huang,Weihong Wei,Yanming Deng,Vasudha Sehgal,Donghui Wang,Jun Jiang,Guoyi Zhang,Anfei Li,Huiling Yang,Francois X. Claret,Francois X. Claret +15 more
TL;DR: Novel biomarkers of metastasis risk are identified using reverse phase protein array profiling of NPC patients at risk for metastasis and considering plasma EBV DNA load in patients with Epstein–Barr virus associated nasopharyngeal carcinoma.
9